Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide plus Topotecan in relapsed or refractory pediatric solid tumors
2008-001436-12Phase 2Active
- Sponsor
- Gustave Roussy
- Start
- May 2008
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide and topotecan in neuroblastoma, medulloblastoma, central nervous system tumor and 1 more, sponsored by Gustave Roussy. Primary endpoint: Objective response rate after 2 cycles. Started May 2008; status: active.
02
Drugs
temozolomidetopotecan
03
Conditions
neuroblastomamedulloblastomacentral nervous system tumorNonhematologic neoplasms
Beyond the preview
Go deeper on 2008-001436-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001436-12.